Global Health Equity

From scientists in research labs to CEOs at companies across the country, here’s how one healthcare company is partnering with people from all walks of life to help drive change in how we treat mental disorders—and the stigma often associated with them.

A new World Health Organization prequalification for mebendazole means the company can reach even more young people with intestinal worm infections around the globe.

It’s been 30 years since the first World AIDS Day was recognized. Jens Van Roey, M.D., shares how a fateful diagnosis coincidentally that same year transformed him from a humble physician into a tireless champion for those afflicted with the disease.

The company has secured a top ranking on the biennial report—which grades companies on their efforts to make medicine more accessible to those in low- and middle-income countries—for the fourth consecutive time.

She was supposed to have a simple procedure to fix a small hole in her heart—then learned it was actually the size of an egg and required heart surgery. For American Heart Month, Cat Oyler, Vice President of Global Public Health, Johnson & Johnson, shares her story of recovery—and why she doesn’t want to be called a survivor.

The company has once again earned a spot on the prestigious list, this time for helping to train surgeons, paramedics and other healthcare providers around the globe through its Johnson & Johnson Institute and other programs.

Preventative HIV innovations. Better access to oncology care. A mobile messaging service for moms. These are just a few of the initiatives underway—and Chairman and CEO Alex Gorsky sits down for an exclusive interview about all of them.

The index looks at companies that do the best job of providing access to medications in developing countries. Johnson & Johnson ranked #2—and here’s why.

Get all the facts about the virus—including what you can do protect yourself, and what Johnson & Johnson is doing to help.